Reduction of Experimental Cerebral Malaria and Its Related Proinflammatory Responses by the Novel Liposome-Based β-Methasone Nanodrug

Figure 2

Brain cytokine and chemokine levels in PbA-infected mice treated with nSSL-BMS. Each symbol represents a single mouse. ∗Significant, 𝑃 value < 0.05. Noninfected control, 𝑛=5. Infected control day 7, 𝑛=10. Empty nSSL day 7, 𝑛=6. nSSL-BMS day 7, 𝑛=9. nSSL-BMS day 11, 𝑛=6. nSSL-BMS day 14, 𝑛=5.

(a)

(b)

(c)

(d)

(e)